MiR-1254 and Regulates Oxaliplatin Resistance in Human Colorectal Cancer Cells

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2021 Feb 2

PMID 33527017

Citations 3

Authors

Yueyang Mou

Nabin He

Mengyang Su

Zihua Zhong

Jiayu Ma

Jianling Liu

Xian Cheng

Penggao Dai

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) remains one of the deadliest diseases in the whole world. Cancer recurrence and chemotherapeutic drug resistance limit the overall survival rate of patients with CRC. This study aimed to discover the latent miRNAs and genes associated with oxaliplatin resistance in CRC cells. The study found that miR-1254 is upregulated in oxaliplatin-resistant CRC cell line HCT116-R compared with its parental cell line HCT116 by transcriptome sequencing and small RNA sequencing. Meanwhile, (multiple EGF-like domains 6) was downregulated in HCT116-R cells. Transient transfection of miR-1254 mimics significantly reduced cell apoptosis, increased HCT116 tolerance to oxaliplatin, and enhanced expression. Furthermore, transfection of miR-1254 inhibitor increased apoptosis, decreased HCT116-R tolerance to oxaliplatin, and reduced expression. In addition, transient transfection of Si enhanced HCT116 cell resistance to oxaliplatin and reduced cell apoptosis. In summary, is a latent functional target of miR-1254 in regulating oxaliplatin resistance and apoptosis in human CRC cells, suggesting a potential therapeutic target for CRC.

Citing Articles

Has_circ_ASH1L acts as a sponge for miR-1254 to promote the malignant progression of cervical cancer by targeting CD36.

Zhang J, Zhang Y, Li X, Bao Y, Yang J Cancer Gene Ther. 2025; 32(2):214-226.

PMID: 39748122 DOI: 10.1038/s41417-024-00866-5.

The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.

Tavakoli Pirzaman A, Ebrahimzadeh Pirshahid M, Babajani B, Rahmati A, Niknezhad S, Hosseinzadeh R Technol Cancer Res Treat. 2023; 22:15330338231206003.

PMID: 37849311 PMC: 10586010. DOI: 10.1177/15330338231206003.

Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance.

Buhagiar A, Seria E, Borg M, Borg J, Ayers D Cancer Drug Resist. 2022; 4(4):934-945.

PMID: 35582382 PMC: 8992439. DOI: 10.20517/cdr.2021.62.

References

Taguchi Y . Identification of More Feasible MicroRNA-mRNA Interactions within Multiple Cancers Using Principal Component Analysis Based Unsupervised Feature Extraction. Int J Mol Sci. 2016; 17(5). PMC: 4881522. DOI: 10.3390/ijms17050696. View

Rasmussen M, Jensen N, Tarpgaard L, Qvortrup C, Romer M, Stenvang J . High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. Mol Oncol. 2013; 7(3):637-46. PMC: 5528477. DOI: 10.1016/j.molonc.2013.02.016. View

Venkatesan N, Deepa P, Khetan V, Krishnakumar S . Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy. Bioinform Biol Insights. 2015; 9:89-101. PMC: 4429751. DOI: 10.4137/BBI.S21742. View

Pu M, Li C, Qi X, Chen J, Wang Y, Gao L . MiR-1254 suppresses HO-1 expression through seed region-dependent silencing and non-seed interaction with TFAP2A transcript to attenuate NSCLC growth. PLoS Genet. 2017; 13(7):e1006896. PMC: 5549757. DOI: 10.1371/journal.pgen.1006896. View

Hu H, Wang M, Wang H, Liu Z, Guan X, Yang R . MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis. Cell Physiol Biochem. 2018; 46(5):1895-1906. DOI: 10.1159/000489374. View

Kim C, Hong Y, Lee H, Kang H, Lee E . MicroRNA-195 desensitizes HCT116 human colon cancer cells to 5-fluorouracil. Cancer Lett. 2017; 412:264-271. DOI: 10.1016/j.canlet.2017.10.022. View

Wang X, Lan Z, He J, Lai Q, Yao X, Li Q . LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells. Cancer Cell Int. 2019; 19:234. PMC: 6734319. DOI: 10.1186/s12935-019-0951-6. View

Liang H, Xu Y, Zhang Q, Yang Y, Mou Y, Gao Y . MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. Artif Cells Nanomed Biotechnol. 2019; 47(1):725-736. DOI: 10.1080/21691401.2019.1569530. View

Wen S, Wang X, Wang Y, Shen J, Pu J, Liang H . Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells. Artif Cells Nanomed Biotechnol. 2018; 46(sup1):896-905. DOI: 10.1080/21691401.2018.1439835. View

10.

Lim J, Hao T, Shaw C, Patel A, Szabo G, Rual J . A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell. 2006; 125(4):801-14. DOI: 10.1016/j.cell.2006.03.032. View

11.

Wang M, Hu H, Wang Y, Huang Q, Huang R, Chen Y . Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer. J Cancer. 2019; 10(19):4603-4613. PMC: 6746119. DOI: 10.7150/jca.32065. View

12.

Krivohlava R, Neuhferova E, Jakobsen K, Benson V . Knockdown of microRNA-135b in Mammary Carcinoma by Targeted Nanodiamonds: Potentials and Pitfalls of In Vivo Applications. Nanomaterials (Basel). 2019; 9(6). PMC: 6632128. DOI: 10.3390/nano9060866. View

13.

Kwon Y, Kim Y, Jung H, Jeoung D . Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance. Int J Mol Sci. 2018; 20(1). PMC: 6337380. DOI: 10.3390/ijms20010051. View

14.

Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X . Impact of the preoperative prognostic nutritional index on postoperative and survival outcomes in colorectal cancer patients who underwent primary tumor resection: a systematic review and meta-analysis. Int J Colorectal Dis. 2019; 34(4):681-689. DOI: 10.1007/s00384-019-03241-1. View

15.

Blower P, Chung J, Verducci J, Lin S, Park J, Dai Z . MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther. 2008; 7(1):1-9. DOI: 10.1158/1535-7163.MCT-07-0573. View

16.

Lu M, Chen W, Wang C, Mao C, Wang J . Reciprocal regulation of miR-1254 and c-Myc in oral squamous cell carcinoma suppresses EMT-mediated metastasis and tumor-initiating properties through MAPK signaling. Biochem Biophys Res Commun. 2017; 484(4):801-807. DOI: 10.1016/j.bbrc.2017.01.170. View

17.

Chen R, Zhang Y, Zhang X . MiR-1254 Functions as a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CD36. Technol Cancer Res Treat. 2019; 18:1533033819859447. PMC: 6691659. DOI: 10.1177/1533033819859447. View

18.

Tariq K, Ghias K . Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol Med. 2016; 13(1):120-35. PMC: 4850121. DOI: 10.28092/j.issn.2095-3941.2015.0103. View

19.

Uddin M, Li M, Wang X . Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma. Cells. 2019; 8(9). PMC: 6769865. DOI: 10.3390/cells8091054. View

20.

Chen J, Hsieh Y, Lo H, Li A, Chou C, Yang P . In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells. Biomolecules. 2019; 9(9). PMC: 6769444. DOI: 10.3390/biom9090467. View